The Prognostic Characteristics and Recurrence Patterns of High Grade Endometrioid Endometrial Cancer: A Large Retrospective Analysis of a Tertiary Center

被引:3
|
作者
Zouridis, Andreas [1 ]
Zarrindej, Kianoush [2 ]
Rencher, Joshua [3 ]
Pappa, Christina [1 ]
Kashif, Ammara [1 ]
Smyth, Sarah Louise [1 ]
Sadeghi, Negin [1 ]
Sattar, Alisha [1 ]
Damato, Stephen [1 ]
Ferrari, Federico [4 ]
Lagana, Antonio Simone [5 ]
Abdalla, Mostafa [6 ]
Kehoe, Sean [1 ]
Addley, Susan [7 ]
Majd, Hooman Soleymani [1 ]
机构
[1] Oxford Univ Hosp NHS Fdn Trust, Oxford OX3 7LE, England
[2] Buckinghamshire NHS Fdn Trust, Wycombe HP11 2TT, Bucks, England
[3] Royal Berkshire NHS Fdn Trust, Reading RG1 5AN, England
[4] Univ Brescia, Dept Clin & Expt Sci, I-25136 Brescia, Italy
[5] Univ Palermo, Dept Hlth Promot Mother & Child Care, Internal Med & Med Specialties PROMISE, Unit Gynecol Oncol,ARNAS Civ Di Cristina Benfratel, I-90127 Palermo, Italy
[6] Guys & St Thomas NHS Fdn Trust, Gynaecol, London SE1 9RT, England
[7] Univ Hosp Derby & Burton NHS Fdn Trust, Derby DE22 3NE, England
关键词
endometrioid endometrial cancer; grade; 3; high grade; prognosis; recurrence; CLEAR-CELL CARCINOMAS; INITIATED FOLLOW-UP; GYNECOLOGICAL MALIGNANCY; SURVIVAL; RECOMMENDATIONS; ADENOCARCINOMA; GUIDELINES; FEATURES; THERAPY; IMPACT;
D O I
10.3390/jcm12093141
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High grade endometrioid endometrial cancer (HGEEC) is a heterogeneous group of tumors with unclear prognostic features. The aim of the present study is to evaluate the independent risk factors for recurrence and mortality and to describe the recurrence patterns of HGEEC. Ninety-six consecutive cases of HGEEC treated with primary surgery in a single Tertiary Center were retrospectively reviewed. Clinicopathological and treatment details were recorded, and all patients were closely followed up. Disease-free, overall and cancer-specific survival rates were 83.8%, 77.8% and 83.6%, respectively. Cervical stromal involvement was independently related to recurrence (HR = 25.67; 95%CI 2.95-223.30; p = 0.003) and cancer-related death (HR = 15.39; 95%CI 1.29-183.43; p = 0.031) after adjusting for other pathological and treatment variables. Recurrence rate was 16%, with 60% of these cases having lung metastases and only one case with single vaginal vault recurrence. 81.81% of the recurrences presented with symptoms and not a single recurrence was diagnosed in routine follow-up clinical examination. In conclusion, the recurrence pattern may suggest that patient-initiated follow-up (PIFU) could be considered a potential alternative to clinical-based follow-up for HGEEC survivors, especially for patients without cervical involvement and after two years from treatment. Additional caution is needed in patients with cervical stromal involvement.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Analysis of prognostic factors and patterns of recurrence in patients with pathologic Stage III endometrial cancer
    Patel, Samir
    Portelance, Lorraine
    Gilbert, Lucy
    Tan, Leonard
    Stanimir, Gerald
    Duclos, Marie
    Souhami, Luis
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (05): : 1438 - 1445
  • [22] Preclinical evaluation of avutometinib and defactinib in high-grade endometrioid endometrial cancer
    Hartwich, Tobias Max Philipp
    Mansolf, Miranda
    Demirkiran, Cem
    Greenman, Michelle
    Bellone, Stefania
    McNamara, Blair
    Nandi, Shuvro P.
    Alexandrov, Ludmil B.
    Yang-Hartwich, Yang
    Coma, Silvia
    Pachter, Jonathan
    Santin, Alessandro D.
    CANCER MEDICINE, 2024, 13 (17):
  • [23] Where does the prognosis of grade 2 endometrioid endometrial cancer stands in the spectrum between low and high grade endometrioid tumours?
    Zouridis, Andreas
    Kashif, Ammara
    Pappa, Christina
    Zarrindej, Kianoush
    Rencher, Joshua
    Smyth, Sarah Louise
    Sadeghi, Negin
    Sattar, Alisha
    Damato, Stephen
    Abdalla, Mostafa
    Kehoe, Sean
    Addley, Susan
    Majd, Hooman Soleymani
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A186 - A186
  • [24] THE ROLE OF PROGNOSTIC RISK FACTORS IN ENDOMETRIAL CANCER RECURRENCE: A RETROSPECTIVE STUDY
    Spagnol, G.
    Pezzani, I.
    Corrao, G.
    Gava, S.
    Bernardini, V.
    Kilzie, S.
    Artioli, G.
    Bonaldo, G.
    Noventa, M.
    Carlo, S.
    Busato, E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A82 - A83
  • [25] Prognostic characteristics, recurrence patterns, and survival outcomes of vulval squamous cell carcinoma - A twelve-year retrospective analysis of a tertiary centre
    Darwish, Ahmed
    Ismail, Lamiese
    Manek, Sanjiv
    Hellner, Karin
    Kehoe, Sean
    Majd, Hooman Soleymani
    EJSO, 2024, 50 (07):
  • [26] Analysis of CpG island methylation in low and high grade endometrial endometrioid adenocarcinoma
    Broaddus, RR
    Xie, SS
    Issa, JPJ
    MODERN PATHOLOGY, 2003, 16 (01) : 183A - 183A
  • [27] Patterns of recurrence and prognostic factors in early-stage endometrial cancer
    Sung, Ji Soo
    Kim, Hak Jae
    Kang, Hyun-Cheol
    Kim, Kyung Su
    Eom, Keun Yong
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1062 - S1064
  • [28] Analysis of CpG island methylation in low and high grade endometrial endometrioid adenocarcinoma
    Broaddus, RR
    Yie, SS
    Issa, JPJ
    LABORATORY INVESTIGATION, 2003, 83 (01) : 183A - 183A
  • [29] SURVIVAL AND PATTERNS OF RECURRENCE IN PATIENTS WITH ENDOMETRIAL CANCER: A SINGLE CENTER STUDY
    Zhang, C.
    Soochit, A.
    Jihong, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 1220 - 1220
  • [30] The prognostic value of squamous differentiation in endometrioid type endometrial cancer: a matched analysis
    Aslan, Koray
    oz, Murat
    Ersak, Burak
    Muftuoglu, Hakan Kamil
    Moraloglu Tekin, Ozlem
    Meydanli, Mehmet Mutlu
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (03) : 494 - 500